Canada markets closed

Sonnet BioTherapeutics Holdings, Inc. (SONN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.8604-0.0696 (-3.61%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-09-30
2022-09-30
2021-09-30
2020-09-30
Total Revenue
129.176
147.805
349.943
483.626
0
Operating Expenses
Research Development
8,713
11,815
21,444
16,635
9,878
Selling General and Administrative
5,875
7,126
8,575
8,937
7,534
Total Operating Expenses
14,588
18,940
30,019
25,571
17,411
Operating Income or Loss
-14,459
-18,793
-29,669
-25,087
-17,411
Total Other Income/Expenses Net
0.033
-40.077
-52.482
103.46
-6,875
Income Before Tax
-14,459
-18,833
-29,722
-24,984
-24,265
Income from Continuing Operations
-14,459
-18,833
-29,722
-24,984
-24,265
Net Income
-14,459
-18,833
-29,722
-24,984
-24,265
Net Income available to common shareholders
-14,459
-18,833
-29,722
-24,984
-65,604
Basic EPS
-18.14
-18.14
-150.52
-313.50
-2.14k
Diluted EPS
-18.14
-18.14
-150.52
-313.50
-2.14k
Basic Average Shares
1,038
1,038
197.462
79.699
30.585
Diluted Average Shares
1,038
1,038
197.462
79.699
30.585